Association of angiopoietin-2 with renal outcome in chronic kidney disease

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Tsai, Yi Chun ^a,b,c   Chiu, Yi Wen ^b,c   Tsai, Jer Chia ^b,c   Kuo, Hung Tien ^b,c   Lee, Su Chu ^b   Hung, Chi Chih ^b,c   Lin, Ming Yen ^c   Hwang, Shang Jyh ^a,b,c,d   Kuo, Mei Chuan ^a,b,c   Chen, Hung Chun ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH INSURANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROTEIN BINDING; PROTEIN TARGETING; UREA NITROGEN BLOOD LEVEL; BLOOD; KIDNEY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84943167924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108862     Document Type: Article

References (38)

1. Nugent RA, Fathima SF, Feigl AB, Chyung D (2011) The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 118: 269-277.
2. Chang FC, Lin SL (2013) The role of angiopoietin-2 in progressive renal fibrosis. J Formos Med Assoc 112: 175-176.
3. Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98: 1014-1023.
4. Fam NP, Verma S, Kutryk M, Stewart DJ (2003) Clinician guide to angiogenesis. Circulation 108: 2613-2618.
5. Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immuno 27: 552-558.
6. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, et al. (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103: 4150-4156.
7. Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S (2002) Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 99: 1646-1650.
8. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
9. Lim HS, Lip GY, Blann AD (2005) Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180: 113-118.
10. Nadar SK, Blann A, Beevers DG, Lip GY (2005) Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 258: 336-343.
11. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY (2004) Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 43: 423-428.
12. David S, Kumpers P, Hellpap J, Horn R, Leitolf H, et al. (2009) Angiopoietin-2 and cardiovascular disease in dialysis and kidney transplantation. Am J Kidney Dis 53: 770-778.
13. Lee KW, Lip GY, Blann AD (2004) Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 110: 2355-2360.
14. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3: e46.
15. Kumpers P, Lukasz A, David S, Horn R, Hafer C, et al. (2008) Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care, 12: R147.
16. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, et al. (2010) Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 36: 462-470.
17. David S, Kumpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, et al. (2010) Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 25: 2571-2576.
18. David S, John SG, Jefferies HJ, Sigrist MK, Kumpers P, et al. (2012) Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 27: 1867-1872.
19. Chang FC, Lai TS, Chiang CK, Chen YM, Wu MS, et al. (2013) Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PloS One, 8: e54668.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
21. Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85: 49-61.
22. Davis B, Dei Cas A, Long DA, White KE, Hayward A, et al. (2007) Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 18: 2320-2329.
23. Woolf AS, Gnudi L, Long DA (2009) Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 20: 239-244.
24. Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401.
25. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716.
26. Seron D, Alexopoulos E, Raftery MJ, Hartley B, Cameron JS (1990) Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage. Nephrol dial transplant 5: 889-893.
27. Futrakul N, Butthep P, Futrakul P (2008) Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc 38: 201-207.
28. Tsai YC, Hung CC, Kuo MC, Tsai JC, Yeh SM, et al. (2012) Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. PloS One, 7: e52775.
29. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J (2006) Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 26: 1002-1007.
30. Rengo G, Cannavo A, Liccardo D, Zincarelli C, de Lucia C, et al. (2013) CVascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure. Circ Heart Fail 6: 1259-67.
31. Chen JX, Zeng H, Reese J, Aschner JL, Meyrick B (2012) Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model. Am J Physiol Heart Circ Physiol 302: 1003-1012.
32. Anuradha S, Mohan V, Gokulakrishnan K, Dixit M (2010) Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74). Metabolism Clinical and Experimental 59: 774-779.
33. Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach, et al. (2011) SAssociation between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med 171: 1920-1927.
34. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, et al (2011) Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis 43: 285-292.
35. Shroff RC, Price KL, Kolatsi-Joannou M, Todd AF, Wells D, et al (2013) Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLOS one 8: e56273.
36. Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, et al. (1999) Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19: 1168-1172.
37. Baylis C (2012) Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 21: 1-6.
38. Kielstein JT, Zoccali C (2005) Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 46: 186-202.